acridine orange has been researched along with Neuroectodermal Tumors in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Amey, JS; Carmena, D; Higgins, CF; Jansen-Rosseck, N; Nebrig, M; Sardini, A; Weylandt, KH; Wiedenmann, B | 1 |
1 other study(ies) available for acridine orange and Neuroectodermal Tumors
Article | Year |
---|---|
ClC-3 expression enhances etoposide resistance by increasing acidification of the late endocytic compartment.
Topics: Acridine Orange; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Proliferation; Cells, Cultured; Chloride Channels; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Endosomes; Etoposide; Genes, MDR; Humans; Immunoenzyme Techniques; Kidney; Muscle Proteins; Neuroectodermal Tumors | 2007 |